Distinct metabolic dependency on BCAA defines cancer stemness and malignancy in human triple-negative breast cancer
Cell Reports · 2026-07 · 45 (7) · 117630
DOI: 10.1016/j.celrep.2026.117630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-07. Verfasst von Kenkyo Matsuura und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cell Fate Dynamics and Therapeutics, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Amino Acids, Branched-Chain, Neoplastic Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) lacks effective molecularly targeted therapies. Here, we identify branched-chain amino acid (BCAA) metabolism as a selective vulnerability in human TNBC, particularly in the claudin-low subtype. TNBC cells show greater dependence on BCAAs than other breast cancer subtypes, and intracellular BCAA levels are heterogeneous within tumors in vivo. Cells with high BCAA levels exhibit enhanced sphere formation and cancer stem cell potential in xenograft models. BCAT1, a cytoplasmic BCAA aminotransferase, is upregulated in claudin-low TNBC and enables tumor growth by promoting BCAA production from branched-chain ketoacids. BCAT1 knockdown impairs TNBC growth in vivo, and high BCAT1 expression predicts poor prognosis in patient cohorts. Conversely, BCAA catabolism via the BCKDH complex is suppressed in TNBC, and reactivation of BCKDH by BCKDK knockout blocks clonogenic growth. These findings reveal BCAA metabolic balance as a key regulator of TNBC stemness and malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cell Fate Dynamics and Therapeutics, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
- Division of Cell Fate Dynamics and Therapeutics, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan; Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
- Institute of Medical Sciences, The University of Tokyo, Tokyo, Japan.
- Division of Cell Fate Dynamics and Therapeutics, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan; Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Institute for Chemical Research, Kyoto University, Kyoto, Japan.
- Hacarus Inc., Kyoto, Japan.
Förderung
- NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- Japan Science and Technology Agency
- Tokyo Biochemical Research Foundation
- Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
- Japan Society for the Promotion of Science
- Naito Foundation
Zitieren
APA
Matsuura, K., Shinonaga, R., Yamamoto, M., Yamamoto, Y., Chen, H., Maeno, A., Okuda, K., Inoue, H., Imotani, S., Glushka, J., Miki, K., Watanabe, Y., Takada, M., Kaji, H., Inoue, J. I., Hattori, A., Imamura, H., & Ito, T. (2026). Distinct metabolic dependency on BCAA defines cancer stemness and malignancy in human triple-negative breast cancer. Cell Reports, 45(7), 117630. https://doi.org/10.1016/j.celrep.2026.117630
Vancouver
Matsuura K, Shinonaga R, Yamamoto M, Yamamoto Y, Chen H, Maeno A, et al. Distinct metabolic dependency on BCAA defines cancer stemness and malignancy in human triple-negative breast cancer. Cell Reports. 2026;45(7):117630. doi:10.1016/j.celrep.2026.117630
BibTeX
@article{Matsuura2026,
author = {Matsuura, Kenkyo and Shinonaga, Ririko and Yamamoto, Mizuki and Yamamoto, Yoshiki and Chen, Hsin and Maeno, Ayaka and Okuda, Kayo and Inoue, Haruki and Imotani, Sota and Glushka, John and Miki, Koji and Watanabe, Yukako and Takada, Mamoru and Kaji, Hironori and Inoue, Jun-Ichiro and Hattori, Ayuna and Imamura, Hiromi and Ito, Takahiro},
title = {Distinct metabolic dependency on BCAA defines cancer stemness and malignancy in human triple-negative breast cancer},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {7},
pages = {117630},
doi = {10.1016/j.celrep.2026.117630}
}
EUVIMED